Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Scribner

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|August 8, 1998
CCR5 genotype and the clinical course of HIV-1 infectionC L Scribner
Developments in Biological Standardization|January 1, 1992
Introduction to the issues: appropriate methods of process validationC L Scribner
Annals of the New York Academy of Sciences|October 13, 1992
An FDA perspective of manufacturing changes for products in human useC N Durfor, C L Scribner
Clinical Immunology and Immunopathology|October 1, 1988
The role of splenic colony-forming units in autoimmune diseaseC L Scribner, A D Steinberg
Cytotechnology|January 1, 1992
Regulatory considerations when developing biological products. Report of the Center for Biologics Evaluation and ResearchR W Kozak, C N Durfor, C L Scribner
Transfusion|February 1, 1997
Decrease in frequency of transfusion fatalitiesJ V Linden, M A Tourault, C L Scribner
The Journal of Infectious Diseases|May 1, 1981
Ecology of ebola virus: a first clue?K M Johnson, C L Scribner, J B McCormick
Annals of Internal Medicine|August 15, 1994
Aseptic meningitis and intravenous immunoglobulin therapyC L Scribner, R M Kapit, E T Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
The interaction of the xid and me genesC L Scribner, C T Hansen, D M Klinman, et al.
Lancet (London, England)|November 22, 1986
No evidence for increased risk of Lassa fever infection in hospital staffC G Helmick, P A Webb, C L Scribner, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|August 8, 1998
CCR5 genotype and the clinical course of HIV-1 infectionC L Scribner
Developments in Biological Standardization|January 1, 1992
Introduction to the issues: appropriate methods of process validationC L Scribner
Annals of the New York Academy of Sciences|October 13, 1992
An FDA perspective of manufacturing changes for products in human useC N Durfor, C L Scribner
Clinical Immunology and Immunopathology|October 1, 1988
The role of splenic colony-forming units in autoimmune diseaseC L Scribner, A D Steinberg
Cytotechnology|January 1, 1992
Regulatory considerations when developing biological products. Report of the Center for Biologics Evaluation and ResearchR W Kozak, C N Durfor, C L Scribner
Transfusion|February 1, 1997
Decrease in frequency of transfusion fatalitiesJ V Linden, M A Tourault, C L Scribner
The Journal of Infectious Diseases|May 1, 1981
Ecology of ebola virus: a first clue?K M Johnson, C L Scribner, J B McCormick
Annals of Internal Medicine|August 15, 1994
Aseptic meningitis and intravenous immunoglobulin therapyC L Scribner, R M Kapit, E T Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
The interaction of the xid and me genesC L Scribner, C T Hansen, D M Klinman, et al.
Lancet (London, England)|November 22, 1986
No evidence for increased risk of Lassa fever infection in hospital staffC G Helmick, P A Webb, C L Scribner, et al.
Pageof 2